REGRESSION-ANALYSIS FOR QSAR USING NEURAL NETWORKS

被引:29
作者
LIVINGSTONE, DJ [1 ]
SALT, DW [1 ]
机构
[1] PORTSMOUTH POLYTECH,SCH MATH STUDIES,PORTSMOUTH PO1 2EG,HANTS,ENGLAND
关键词
D O I
10.1016/S0960-894X(01)81067-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Neural networks have been used to analyse QSAR data giving promising results. However, there is the danger of chance "correlations" and "over-fitting". We have examined a reported analysis and shown that the size of the hidden layer can be reduced giving more efficient training while maintaining predictive performance.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 15 条
[1]   APPLICATIONS OF NEURAL NETWORKS IN QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF DIHYDROFOLATE-REDUCTASE INHIBITORS [J].
ANDREA, TA ;
KALAYEH, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (09) :2824-2836
[2]   NEURAL NETWORKS APPLIED TO PHARMACEUTICAL PROBLEMS .3. NEURAL NETWORKS APPLIED TO QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP ANALYSIS [J].
AOYAMA, T ;
SUZUKI, Y ;
ICHIKAWA, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) :2583-2590
[3]   NEURAL NETWORKS APPLIED TO STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
AOYAMA, T ;
SUZUKI, Y ;
ICHIKAWA, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) :905-908
[4]  
CLERC JT, 1973, CHIMIA, V27, P639
[5]  
EBERHART RC, 1990, NEURAL NETWORK PC TO, P42
[6]   APPLICATION OF PATTERN-RECOGNITION TO SCREENING PROSPECTIVE ANTICANCER DRUGS - ADENOCARCINOMA-755 BIOLOGICAL-ACTIVITY TEST [J].
KOWALSKI, BR ;
BENDER, CF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1974, 96 (03) :916-918
[7]   STRUCTURE-ACTIVITY CORRELATIONS OBTAINED USING PATTERN-RECOGNITION METHODS - COMMENT [J].
MATHEWS, RJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1975, 97 (04) :935-936
[8]   PREDICTION OF BETA-TURNS IN PROTEINS USING NEURAL NETWORKS [J].
MCGREGOR, MJ ;
FLORES, TP ;
STERNBERG, MJE .
PROTEIN ENGINEERING, 1989, 2 (07) :521-526
[9]   PREDICTION OF THE DISULFIDE-BONDING STATE OF CYSTEINE IN PROTEINS [J].
MUSKAL, SM ;
HOLBROOK, SR ;
KIM, SH .
PROTEIN ENGINEERING, 1990, 3 (08) :667-672
[10]  
NAKOA H, 1972, PHARM B, V20, P1968